Friends
In Part 6 of my interview from iwCLL, I push Dr. Sharman to spectate on the issues of 17 p deletion and of the importance of residual disease with ibrutinib and idelalisib.
See bkoffman.blogspot.com This is a very interesting segment for me.
Thanks to all who sent well wishes and prayers. While I am not yet well, I am getting better.
Stay strong
Brian